<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160621028567N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-10</date_registration>
      <primary_sponsor>Tarbiat Modares University</primary_sponsor>
      <public_title>Effect of Cervical Spine Manual Therapy on the Electrophysiological Findings in the Migraineur Subjects with Neck Pain</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Upper Cervical Spine Manual Therapy on the Clinical and Physical Signs and Symptoms, Disability, and Electrophysiological Findings in the Migraineur Subjects with Neck Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52879</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Eligible individuals will be randomly assigned to groups 1 through 4 after the initial evaluation by a researcher who is not involved in the evaluations. In order to preserve allocation concealment, the subjects will be included in the study in 1:1 ratio by a random block of 2 using a sealed envelope, Blinding description: Assignments to study groups will be kept from the analyzer researcher, assessor researcher, and the participants. In order to blind the subjects, the sham intervention will be performed with the same force, palpation, and duration as the main intervention. Another independent researcher will perform statistical analysis and result interpretation. For obvious reasons, healthcare providers cannot be kept blinded.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Migraine. Condition 2: Neck Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: upper cervical spine manual therapy in 4 sessions. To perform manual therapy, the patient will be in a supine position and the physiotherapist will stand above the patient. The physiotherapist will then place his or her pointer finger on the articular processes t of the target segment (C1-C2). The other fingers of the physiotherapist will be spread over the patient's neck. The physiotherapist will then apply 5 times a 30-second nonthrust pressure to the C0 / C1 and C1 / C2 articular processes in a posterior-anterior displacement, lateral displacement, or rotation, in a direction that does not reproduce the headache symptoms. . Intervention 2: Intervention group: Sham upper cervical manual therapy in 4 sessions. The sham manual therapy will be performed as follows: the physiotherapist's hands will be in wide and non-specific contact with the person's neck, and the therapy will be a fake maneuver of pushing the vertebrae at a low speed and amplitude in a non-therapeutic direction. Intervention 3: Intervention group: without manual therapy interventions. Intervention 4: Intervention group: Migraine group without neck pain (without manual therapy intervention). Intervention 5: Control group: : Control group: healthy subjects of the same age (without migraine and neck pain).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
a  part of data

When:
6 months after publications

To whom:
Researchers

Conditions:
for treatment and research goals

Where to obtain:
Farid Bahrpeyma

How to obtain:
Confirmation of advisor professors

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farid Bahrpeyma</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jalal Ale Ahmad, Nasr</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 3819</telephone>
        <email>bahrpeyf@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farid Bahrpeyma</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jalal Ale Ahmad, Nasr</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713116</zip>
        <telephone>+98 21 8288 3819</telephone>
        <email>bahrpeyf@modares.ac.ir</email>
        <affiliation>Tarbiat Modares University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Migraine according to IHS criteria at least three days a month
Neck pain (more than 30% NDI and at least one symptomatic segment according to PAIVMs in the upper cervical spine) with migraine
Age between 18 and 50 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Other primary or secondary headaches
Other neurological diseases
Severe physical / psychiatric limitations
Ear disorders
Medication Overuse Headache
Systemic diseases such as fibromyalgia or rheumatoid arthritis
Vertebrobasilar insufficiency / atherosclerosis of cervical arteries
Cervical spine instability and alar and transverse ligament defects
Nerve blocks in the last 6 months
Neck and shoulder physiotherapy treatments in the last 6 months
Malignancies</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G43</hc_code>
      <hc_code>G54.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Migraine</hc_keyword>
      <hc_keyword>Cervical root disorders, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
      <i_code>Other</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: upper cervical spine manual therapy in 4 sessions. To perform manual therapy, the patient will be in a supine position and the physiotherapist will stand above the patient. The physiotherapist will then place his or her pointer finger on the articular processes t of the target segment (C1-C2). The other fingers of the physiotherapist will be spread over the patient's neck. The physiotherapist will then apply 5 times a 30-second nonthrust pressure to the C0 / C1 and C1 / C2 articular processes in a posterior-anterior displacement, lateral displacement, or rotation, in a direction that does not reproduce the headache symptoms. .</i_keyword>
      <i_keyword>Intervention group: Sham upper cervical manual therapy in 4 sessions. The sham manual therapy will be performed as follows: the physiotherapist's hands will be in wide and non-specific contact with the person's neck, and the therapy will be a fake maneuver of pushing the vertebrae at a low speed and amplitude in a non-therapeutic direction.</i_keyword>
      <i_keyword>Intervention group: without manual therapy interventions</i_keyword>
      <i_keyword>Intervention group: Migraine group without neck pain (without manual therapy intervention)</i_keyword>
      <i_keyword>Control group: : Control group: healthy subjects of the same age (without migraine and neck pain)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Headache Intensity. Timepoint: At the beginning of the study, one month after end of interventions. Method of measurement: Designed form for recording the clinical characteristics of headache.</prim_outcome>
      <prim_outcome>Headache Frequency. Timepoint: At the beginning of the study, one month after end of interventions. Method of measurement: Designed form for recording the clinical characteristics of headache.</prim_outcome>
      <prim_outcome>Pain killer medications. Timepoint: At the beginning of the study, one month after end of interventions. Method of measurement: Designed form for recording the clinical characteristics of headache.</prim_outcome>
      <prim_outcome>Headache Duration. Timepoint: At the beginning of the study, one month after end of interventions. Method of measurement: Designed form for recording the clinical characteristics of headache.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Wave I latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>Wave II latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>Wave III latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>Wave IV latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>Wave IV latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>I-III interpeak latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>III-IV interpeak latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>I-IV interpeak latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Brain Auditory Evoked Response.</sec_outcome>
      <sec_outcome>R1 latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Blink Reflex.</sec_outcome>
      <sec_outcome>R2 latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Blink Reflex.</sec_outcome>
      <sec_outcome>R2 contralateral latency. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Blink Reflex.</sec_outcome>
      <sec_outcome>Cervical flexion range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Cervical extension range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Cervical right rotation range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Cervical left rotation range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Cervical right lateral flexion range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Cervical left lateral flexion range of motion. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Flexion-rotation test. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: iPhone compass application.</sec_outcome>
      <sec_outcome>Manual examination of upper cervical spine joints. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Manual.</sec_outcome>
      <sec_outcome>Visual examination of upper cervical subluxation. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Visual.</sec_outcome>
      <sec_outcome>Headache Impact Test score. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Persian HIT-6 questionnaire.</sec_outcome>
      <sec_outcome>Neck Disability Index Score. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Persian NDI questionnaire.</sec_outcome>
      <sec_outcome>Central Sensitivity Index score. Timepoint: At the beginning of the study, one month after the end of the study. Method of measurement: Persian CSI questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tarbiat Modares University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-11-09</approval_date>
        <contact_name>Research Ethics Committee of Tarbiat Modares University</contact_name>
        <contact_address>Jalal AleAhmad Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
